Hide metadata

dc.date.accessioned2018-11-06T12:43:43Z
dc.date.available2018-11-06T12:43:43Z
dc.date.created2017-11-10T12:49:07Z
dc.date.issued2017
dc.identifier.citationWood, Mollie Lapane, Kate L van Gelder, Marleen MHJ Rai, Dheeraj Nordeng, Hedvig Marie Egeland . Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control. Pharmacoepidemiology and Drug Safety. 2017, 27(2), 140-147
dc.identifier.urihttp://hdl.handle.net/10852/65411
dc.description.abstractUnderstanding the safety of medication use during pregnancy relies on observational studies: However, confounding in observational studies poses a threat to the validity of estimates obtained from observational data. Newer methods, such as marginal structural models and propensity calibration, have emerged to deal with complex confounding problems, but these methods have seen limited uptake in the pregnancy medication literature. In this article, we provide an overview of newer advanced methods for confounding control and show how these methods are relevant for pregnancy medication safety studies.en_US
dc.languageEN
dc.titleMaking fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding controlen_US
dc.title.alternativeENEngelskEnglishMaking fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control
dc.typeJournal articleen_US
dc.creator.authorWood, Mollie
dc.creator.authorLapane, Kate L
dc.creator.authorvan Gelder, Marleen MHJ
dc.creator.authorRai, Dheeraj
dc.creator.authorNordeng, Hedvig Marie Egeland
cristin.unitcode185,15,23,10
cristin.unitnameFarmasi
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode2
dc.identifier.cristin1512938
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Pharmacoepidemiology and Drug Safety&rft.volume=27&rft.spage=140&rft.date=2017
dc.identifier.jtitlePharmacoepidemiology and Drug Safety
dc.identifier.volume27
dc.identifier.issue2
dc.identifier.startpage140
dc.identifier.endpage147
dc.identifier.doihttp://dx.doi.org/10.1002/pds.4336
dc.identifier.urnURN:NBN:no-68186
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1053-8569
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/65411/1/Key%2Bconsiderations%2Bmanuscript%2BPEER%2BREVIEWED%2BFOR%2BSELF%2BARCHIVE.pdf
dc.type.versionAcceptedVersion


Files in this item

Appears in the following Collection

Hide metadata